Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Catherine Passariello is active.

Publication


Featured researches published by Catherine Passariello.


Acta Paediatrica | 2010

Adipocytokines and bone mineral density in adolescent female athletes

Rita Gruodytė; Jaak Jürimäe; Antonio Cicchella; Claudio Stefanelli; Catherine Passariello; Toivo Jürimäe

Aim:  To evaluate the relationships of visfatin, adiponectin and leptin with bone mineral density (BMD) and bone mineral content (BMC) in adolescent female athletes with different training patterns.


Biochemical and Biophysical Research Communications | 2011

Upregulation of SIRT1 deacetylase in phenylephrine-treated cardiomyoblasts.

Catherine Passariello; Maddalena Zini; Paolo Nassi; Carla Pignatti; Claudio Stefanelli

The sirtuin SIRT1 is an ubiquitous NAD(+) dependent deacetylase that plays a role in biological processes such as longevity and stress response. In cardiac models, SIRT1 is associated to protection against many stresses. However, the link between SIRT1 and heart hypertrophy is complex and not fully understood. This study focuses specifically on the response of SIRT1 to the α-adrenergic agonist phenylephrine in H9c2 cardiac myoblasts, a cell model of cardiac hypertrophy. After 24 and 48h of phenylephrine treatment, SIRT1 expression and deacetylase activity were significantly increased. SIRT1 upregulation by phenylephrine was not associated to changes in NAD(+) levels, but was blocked by inhibitors of AMP-activated Protein Kinase (AMPK) or by AMPK knockdown by siRNA. When SIRT1 was inhibited with sirtinol or downregulated by siRNA, H9c2 cell viability was significantly decreased following phenylephrine treatment, showing that SIRT1 improves cell survival under hypertrophic stress. We so then propose that the increase in SIRT1 activity and expression in H9c2 cells treated with phenylephrine is an adaptive response to the hypertrophic stress, suggesting that adrenergic stimulation of heart cells activates hypertrophic programming and at the same time also promotes a self-protecting and self-regulating mechanism.


Chemico-Biological Interactions | 2009

Cytotoxicity of methoctramine and methoctramine-related polyamines.

Maddalena Zini; Catherine Passariello; Davide Gottardi; Silvia Cetrullo; Flavio Flamigni; Carla Pignatti; Anna Minarini; Vincenzo Tumiatti; Andrea Milelli; Carlo Melchiorre; Claudio Stefanelli

Methoctramine and its analogues are polymethylene tetramines that selectively bind to a variety of receptor sites. Although these compounds are widely used as pharmacological tools for receptor characterization, the toxicological properties of these polyamine-based structures are largely unknown. We have evaluated the cytotoxic effects of methoctramine and related symmetrical analogues differing in polymethylene chain length between the inner nitrogens against a panel of cell lines. Methoctramine caused cell death only at high micromolar concentrations, whereas its pharmacological action is exerted at nanomolar level. Increasing the spacing between the inner nitrogen atoms resulted in a significative increase in cytotoxicity. In particular, an elevated cytotoxicity is associated to a methylene chain length of 12 units dividing the inner amine functions (compound 5). H9c2 cardiomyoblasts were the most sensitive cells, followed by SH-SY5Y neuroblastoma, whereas HL60 leukaemia cells were much more resistant. Methoctramine and related compounds down-regulated ornithine decarboxylase, the first enzyme of polyamine biosynthesis even at non-toxic concentration. Further, methoctramine and compound 5 caused a limited up-regulation of spermine/spermidine N-acetyltransferase, suggesting that interference in polyamine metabolism is not a primary mechanism of toxicity. Methoctramine and its analogues bound to DNA with a higher affinity than spermine, but the correlation with their toxic effect was poor. The highly toxic compound 5 killed the cells in the absence of caspase activation and caused an increase in p53 expression and ERK1/2 phosphorylation. Compound 5 was directly oxidized by cell homogenates producing hydrogen peroxide and its toxic effect was partially subdued by the inhibition of its uptake, by the NMDA ligand MK-801, and by the antioxidant N-acetylcysteine, suggesting that compound 5 can act at different cellular levels and lead to oxidative stress.


Biochimica et Biophysica Acta | 2012

Evidence that AMP-activated protein kinase can negatively modulate Ornithine decarboxylase activity in cardiac myoblasts

Catherine Passariello; Davide Gottardi; Silvia Cetrullo; Maddalena Zini; Gabriele Campana; Benedetta Tantini; Carla Pignatti; Flavio Flamigni; Carlo Guarnieri; Claudio Marcello Caldarera; Claudio Stefanelli

The responses of AMP-activated protein kinase (AMPK) and Ornithine decarboxylase (ODC) to isoproterenol have been examined in H9c2 cardiomyoblasts, AMPK represents the link between cell growth and energy availability whereas ODC, the key enzyme in polyamine biosynthesis, is essential for all growth processes and it is thought to have a role in the development of cardiac hypertrophy. Isoproterenol rapidly induced ODC activity in H9c2 cardiomyoblasts by promoting the synthesis of the enzyme protein and this effect was counteracted by inhibitors of the PI3K/Akt pathway. The increase in enzyme activity became significant between 15 and 30min after the treatment. At the same time, isoproterenol stimulated the phosphorylation of AMPKα catalytic subunits (Thr172), that was associated to an increase in acetyl coenzyme A carboxylase (Ser72) phosphorylation. Downregulation of both α1 and α2 isoforms of the AMPK catalytic subunit by siRNA to knockdown AMPK enzymatic activity, led to superinduction of ODC in isoproterenol-treated cardiomyoblasts. Downregulation of AMPKα increased ODC activity even in cells treated with other adrenergic agonists and in control cells. Analogue results were obtained in SH-SY5Y neuroblastoma cells transfected with a shRNA construct against AMPKα. In conclusion, isoproterenol quickly activates in H9c2 cardiomyoblasts two events that seem to contrast one another. The first one, an increase in ODC activity, is linked to cell growth, whereas the second, AMPK activation, is a homeostatic mechanism that negatively modulates the first. The modulation of ODC activity by AMPK represents a mechanism that may contribute to control cell growth processes.


Journal of Pediatric Endocrinology and Metabolism | 2011

Plasma visfatin and adiponectin concentrations in physically active adolescent girls: relationships with insulin sensitivity and body composition variables.

Jaak Jürimäe; Rita Gruodytė; Meeli Saar; Antonio Cicchella; Claudio Stefanelli; Catherine Passariello; Katre Maasalu; Toivo Jürimäe; Serge P. von Duvillard

Abstract The purpose of this study was to evaluate the associations of visfatin and adiponectin concentrations with insulin resistance and body composition in regularly physically active pubertal girls. In 129 girls, aged 13–15 years (pubertal stages 3–5), visfatin, adiponectin, insulin resistance measured by homeostasis model assessment (HOMA), and body composition measured by dual-energy X-ray absorptiometry were evaluated. Visfatin concentration was related to HOMA and overall adiposity (body mass index, fat mass) markers, whereas adiponectin concentration was related to overall adiposity (fat mass), central adiposity (trunk fat) and fat free mass values. These relationships remained significant (p<0.05) after adjusting for pubertal stage. Visfatin was independently related to body mass index (β=0.936; p=0.0001) and HOMA (β=0.444; p=0.039) indices, whereas adiponectin was independently related to fat free mass (β=0.889; p=0.003) and trunk fat (β=–0.468; p=0.042) values. In conclusion, visfatin could be related to insulin resistance and overall adiposity indices, whereas adiponectin was related to different body composition values in regularly physically active pubertal girls.


American Journal of Human Biology | 2010

ADIPOQ SNP45 associated with lean body mass in physically active normal weight adolescent girls.

Catherine Passariello; Rita Gruodytė; Kelli Hiio; Jarek Mäestu; Jaak Jürimäe; Melli Saar; Antonio Cicchella; Claudio Stefanelli; Toivo Jürimäe

Recently, two single nucleotide polymorphisms at position 45 and 276 on the adiponectin gene (ADIPOQ) have been recognized as determinants of total adiponectin levels, insulin resistance, and risk for diabetes in various obese populations.


Journal of Human Sport and Exercise | 2009

ANTHROPOMETRIC COMPARISON BETWEEN YOUNG ESTONIAN AND CHINESE SWIMMERS

Antonio Cicchella; Li Jidong; Toivo Jürimäe; Maddalena Zini; Catherine Passariello; Rizzo L; Claudio Stefanelli


Acta Kinesiologiae Universitatis Tartuensis | 2012

Bone mineral density and hormonal status in adolescent athletic girls

Rita Gruodytė-Račienė; Jaak Jürimäe; Meeli Saar; Antonio Cicchella; Claudio Stefanelli; Catherine Passariello; Toivo Jürimäe


Medicine and Science in Sports and Exercise | 2010

Lean Body Mass Associated With Adipoq Snp45 In Physically Active Normal Body Weight Adolescence Girls

Priit Purge; Saar Meeli; Catherine Passariello; Claudio Stefanelli; Jaak Jürimäe; Jarek Mäestu; Antonia Cicchella; Toivo Jürimäe


Medicine and Science in Sports and Exercise | 2010

Visfatin and Adiponectin: Body Fat and Metabolic Factors in Physically Active Girls: 1622

Jaak Jürimäe; Rita Gruodyte; Meeli Saar; Antonio Cicchella; Claudio Stefanelli; Catherine Passariello; Katre Maasalu; Toivo Jürimäe; Serge P. von Duvillard

Collaboration


Dive into the Catherine Passariello's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge